My stock market pieces have been syndicated for the past several years across several news sites. That includes TheStreet, Forbes, Yahoo Finance, NBC News, The Motley Fool, Google Finance, Insider Monkey and Seeking Alpha.
I spent almost 10 years heading the coverage of the municipal bond industr...
As U.S. officials wrangle over funding Medicaid and Medicare, industry players are facing charges that they made illegal investments and trades to earn profits from the health care programs. Last week, the U.S. Securities and Exchange Commission announced charges against several people allegedly to have participated in a trading scheme involving confidential government information. The news comes amid constant media reports of leaks and misuse of government classified information.
One of the pharmaceutical companies that has caused investors angst, whiplash, and constant grabs for the Pepto Bismol, is MannKind (NASDAQ: MNKD). Its stock has traded all over the place as investors have reacted to a slew of news that don't pan out and therefore don't improve its value. However, a recent report gives reason for optimism for those who can stomach dealing with the likelihood of more volatility.
Last week’s WannaCry cyber attack caused chaos around the world. Workers arriving at their jobs were greeted with warnings that their computers could be infected with a virus by parties unknown who were trying to collect a ransom. The virus spared no industry with widespread reports of infections making headlines around the world. It is estimated that 200,000 computers in about 150 countries were infected, according to Europol Director Rob Wainwright.